Literature DB >> 20717872

Oxymatrine, the main alkaloid component of Sophora roots, protects heart against arrhythmias in rats.

Gan Runtao1, Dong Guo, Yu Jiangbo, Wang Xu, Yang Shusen.   

Abstract

Oxymatrine is one of the main alkaloid components extracted from SOPHORA roots and has been shown to play various protective roles in the cardiovascular system. The present study was designed to study the protective effect of oxymatrine on arrhythmias and their ionic channel mechanism. Rat arrhythmic models were established by aconitine injection and coronary artery ligation. Rat cardiomyocytes were acutely isolated, and the whole-cell patch clamp technique was employed to investigate the effects of oxymatrine on sodium channels. Pretreatment with oxymatrine markedly increased the dose of aconitine required to induce arrhythmias in rats. Additionally, oxymatrine significantly delayed the initial time and shortened the duration time of rat arrhythmias induced by coronary artery ligation. Cardiac mortality rate in coronary artery ligation-induced arrhythmias was also effectively decreased by oxymatrine in rats. The electrophysiological study showed that oxymatrine could significantly inhibit sodium and calcium currents in isolated rat cardiomyocytes in a concentration-dependent manner. In summary, oxymatrine plays a remarkably preventive role in rat arrhythmias through the inhibition of sodium and calcium currents. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717872     DOI: 10.1055/s-0030-1250256

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

Review 1.  The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms.

Authors:  Jie Li; Dan Hu; Xiaoli Song; Tao Han; Yonghong Gao; Yanwei Xing
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

2.  Protective effects of oxymatrine against arsenic trioxide-induced liver injury.

Authors:  Li Li; Qinghai Liu; Long Fan; Wei Xiao; Lei Zhao; Yu Wang; Weiguang Ye; Fei Lan; Bin Jia; Hua Feng; Changman Zhou; Xiuqin Yue; Guogang Xing; Tianlong Wang
Journal:  Oncotarget       Date:  2017-02-21

3.  Inhibitory effects of oxymatrine on TGF‑β1‑induced proliferation and abnormal differentiation in rat cardiac fibroblasts via the p38MAPK and ERK1/2 signaling pathways.

Authors:  Yini Xu; Hai Xiao; Hong Luo; Yan Chen; Yanyan Zhang; Ling Tao; Yan Jiang; Yuqi Chen; Xiangchun Shen
Journal:  Mol Med Rep       Date:  2017-08-17       Impact factor: 2.952

Review 4.  Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence.

Authors:  Danesh Soltani; Bayan Azizi; Roja Rahimi; Azita H Talasaz; Hossein Rezaeizadeh; Ali Vasheghani-Farahani
Journal:  Front Cardiovasc Med       Date:  2022-09-29

5.  Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling.

Authors:  Ting-Ting Xiao; Yuan-Yuan Wang; Yan Zhang; Cong-Hui Bai; Xiang-Chun Shen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

6.  Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4.

Authors:  Wenqin Liu; Jian Shi; Lijun Zhu; Lingna Dong; Feifei Luo; Min Zhao; Ying Wang; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  Drug Des Devel Ther       Date:  2015-10-30       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.